Enliven Therapeutics (ELVN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Sam ...

The global major depressive disorder (MDD) treatment market is expected to experience steady growth, projected to develop at ...

The global fatty liver treatment market, valued at approximately USD 20 Billion in 2022, is anticipated to witness ...

As drugmakers take lessons from oncology in developing CAR T cells for other diseases, they must contend with risks that ...

I think we can do better.” Cortes disclosed consulting for Amphivena, Astellas, Bio-Path, BioLineRx, Bristol Myers Squibb, ...

United Therapeutics' pipeline and Tyvaso DPI drive strong growth. Read why UTHR stock offers substantial upside with ...

Analysts have set 12-month price targets for Incyte, revealing an average target of $73.69, a high estimate of $97.00, and a ...

Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.

A fireside chat with a Tamika D. Mallory will go down at sunset to inspire attendees. Powered by Novartis, Grow with Google, Chase for Business, and Barbados Tourism Marketing, the Pow(H)er Experience ...

The FDA issued its first stamp of approval for a cell or gene therapy back in 2017 to Novartis' Kymriah. | The gene therapy ...